PIK3R5 genetic predictors of hypertension induced by VEGF-pathway inhibitors-Reference-Cited by-同舟云学术

PIK3R5 genetic predictors of hypertension induced by VEGF-pathway inhibitors

Published:2021-11-13 Issue:1 Volume:22 Page:82-88
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Quintanilha Julia C. F.^ORCID,Racioppi Alessandro,Wang Jin,Etheridge Amy S.,Denning Stefanie,Peña Carol E.,Skol Andrew D.,Crona Daniel J.^ORCID,Lin Danyu,Innocenti Federico^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

https://www.nature.com/articles/s41397-021-00261-5.pdf

Reference38 articles.

1. Wilhelm SM, Carter C, Tang LY, Wilkie D, McNabola A, Rong H, et al. BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. Cancer Res. 2004;64:7099–109.

2. Nexavar (Sorafenib). 2018. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021923s020lbl.pdf. Accessed 28 Jul 2020.

3. Costa LJ, Drabkin HA. Renal cell carcinoma: new developments in molecular biology and potential for targeted therapies. Oncologist. 2007;12:1404–15.

4. Li Y, Li S, Zhu Y, Liang X, Meng H, Chen J, et al. Incidence and risk of sorafenib-induced hypertension: a systematic review and meta-analysis. J Clin Hypertens. 2014;16:177–85.

5. Mir O, Coriat R, Cabanes L, Ropert S, Billemont B, Alexandre J, et al. An observational study of bevacizumab-induced hypertension as a clinical biomarker of antitumor activity. Oncologist. 2011;16:1325–32.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Contrastive-Learning-Based Deep Neural Network for Cancer Subtyping by Integrating Multi-Omics Data;Interdisciplinary Sciences: Computational Life Sciences;2024-09-04

2. Efficacy and safety of ramucirumab for gastric or gastro-esophageal junction adenocarcinoma: a systematic review and meta-analysis;European Journal of Clinical Pharmacology;2024-08-05

3. Understanding Sorafenib-Induced Cardiovascular Toxicity: Mechanisms and Treatment Implications;Drug Design, Development and Therapy;2024-03

4. Abordagem de Bioinformática e Biologia de Sistemas para Identificar a Ligação Patogenética entre Insuficiência Cardíaca e Sarcopenia;Arquivos Brasileiros de Cardiologia;2023-10

5. Screening and identification of key biomarkers in diabetic kidney disease and its complications: Evidence from bioinformatics and next generation sequencing data analysis;2023-04-18